Advate 1 UNT Injection
- RxCUI
- 1719225
- RxNorm name
- Advate 1 UNT Injection
- Display name
- Advate 1 UNT Injection
- Full name
- Advate 1 UNT Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125063 | Advate | Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method | 351(a) | Rx | 2026-10-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADVATE | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | Takeda Pharmaceuticals America, Inc. | 80fa03d2-cd4c-4155-9b57-1396c4fa42da | 2025-04-03 | Warnings, Adverse reactions | 1719225 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 80fa03d2-cd4c-4155-9b57-1396c4fa42da | Advate 1 UNT Injection [PSN] · antihemophilic factor, human recombinant 1 UNT Injection [Advate] [SBD] · Advate 1 UNT Injection [SY] | 3 | 13 | These highlights do not include all the information needed to use ADVATE ® safely and effectively. See full prescribing information for ADVATE. ADVATE [antihemophilic factor (recombinant)] lyophilized powder for reconstitution, for intravenous injection Initial U.S. Approval: 2003 | 20250403 |